Dimensional Fund Advisors’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Dimensional Fund Advisors’s Portfolio THRX Stock Details THRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-44,145	Closed	-$179K	–	3454
2023 Q4	$179K	Sell	44,145 -2,008	-4%	-$6.13K	﹤0.01%	3209
2023 Q3	$124K	Sell	46,153 -32,840	-42%	-$129K	﹤0.01%	3292
2023 Q2	$737K	Buy	+78,993	New	+$778K	﹤0.01%	2987

Dimensional Fund Advisors's THRX Position: Q1 2024 in Review

Dimensional Fund Advisors sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q1 2024, closing a stake of 44,145 shares — an estimated $179K sold.

Dimensional Fund Advisors first reported a position in THRX in Q2 2023 and held it in 3 quarters. The position peaked at $737K in Q2 2023. 1 fund tracked by Wall St. Rank holds THRX as of Q1 2024.

Dimensional Fund Advisors reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Dimensional Fund Advisors sold 44,145 Theseus Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $179K.
Dimensional Fund Advisors first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q2 2023 and held it in 3 quarters.
Dimensional Fund Advisors's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $737K in Q2 2023.
1 fund tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Dimensional Fund Advisors's 13F filing for Q1 2024, filed 10 May 2024.